| Literature DB >> 32036601 |
Lingyun Wu1, Sugandha Saxena1, Rakesh K Singh2.
Abstract
Neutrophils are the first responders to inflammation, infection, and injury. As one of the most abundant leukocytes in the immune system, neutrophils play an essential role in cancer progression, through multiple mechanisms, including promoting angiogenesis, immunosuppression, and cancer metastasis. Recent studies demonstrating elevated neutrophil to lymphocyte ratios suggest neutrophil as a potential therapeutic target and biomarker for disease status in cancer. This chapter will discuss the phenotypic and functional changes in the neutrophil in the tumor microenvironment, the underlying mechanism(s) of neutrophil facilitated cancer metastasis, and clinical potential of neutrophils as a prognostic/diagnostic marker and therapeutic target.Entities:
Keywords: Angiogenesis; CXCR2 ligands; IL17; Metastasis; NETs; NLR; Neutrophil; Neutrophil-released proteases; Pro-tumor chemokines; Pro-tumor cytokines; Tumor microenvironment
Mesh:
Year: 2020 PMID: 32036601 PMCID: PMC7325741 DOI: 10.1007/978-3-030-35723-8_1
Source DB: PubMed Journal: Adv Exp Med Biol ISSN: 0065-2598 Impact factor: 2.622